Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Ovarian epithelial cancer Medicine & Life Sciences
Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2017

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers

Reiss, K. A., Herman, J. M., Armstrong, D., Zahurak, M., Fyles, A., Brade, A., Milosevic, M., Dawson, L. A., Scardina, A., Fischer, P., Hacker-Prietz, A., Kinders, R. J., Wang, L., Chen, A., Temkin, S., Horiba, N., Stayner, L. A., Siu, L. L. & Azad, N. S. Mar 1 2017 In : Gynecologic Oncology. 144, 3, p. 486-490 5 p.

Research output: Research - peer-reviewArticle

Fallopian Tube Neoplasms
Radiotherapy
Carcinoma
Neoplasms
veliparib

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

Oliver, K. E., Brady, W. E., Birrer, M., Gershenson, D. M., Fleming, G., Copeland, L. J., Tewari, K., Argenta, P. A., Mannel, R. S., Secord, A. A., Stephan, J. M., Mutch, D. G., Stehman, F. B., Muggia, F. M., Rose, P. G., Armstrong, D. K., Bookman, M. A., Burger, R. A. & Farley, J. H. 2017 (Accepted/In press) In : Gynecologic Oncology.

Research output: Research - peer-reviewArticle

Platinum
Ovarian Neoplasms
Disease-Free Survival
Carcinoma
Survival

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): A multicentre, open-label, randomised, phase 3 trial

Coleman, R. L., Brady, M. F., Herzog, T. J., Sabbatini, P., Armstrong, D. K., Walker, J. L., Kim, B. G., Fujiwara, K., Tewari, K. S., O'Malley, D. M., Davidson, S. A., Rubin, S. C., DiSilvestro, P., Basen-Engquist, K., Huang, H., Chan, J. K., Spirtos, N. M., Ashfaq, R. & Mannel, R. S. 2017 (Accepted/In press) In : The Lancet Oncology.

Research output: Research - peer-reviewArticle

Carboplatin
Paclitaxel
Platinum
Ovarian Neoplasms
Drug Therapy
Myositis
Rheumatic Diseases
Autoantibodies
Breast Neoplasms
Neoplasms

Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Moore, K. N., Tritchler, D., Kaufman, K. M., Lankes, H., Quinn, M. C. J., Van Le, L., Berchuck, A., Backes, F. J., Tewari, K. S., Lee, R. B., Kesterson, J. P., Wenham, R. M., Armstrong, D. K., Krivak, T. C., Bookman, M. A. & Birrer, M. J. 2017 (Accepted/In press) In : Gynecologic Oncology.

Research output: Research - peer-reviewArticle

Genome-Wide Association Study
Single Nucleotide Polymorphism
Neoplasms
Survival
Optical Devices